Takeda Pharmaceutical Co. Ltd.

06/27/2022 | Press release | Distributed by Public on 06/27/2022 04:09

Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine